Skip to main content
. 2021 May 18;13:4013–4029. doi: 10.2147/CMAR.S304591

Figure 4.

Figure 4

Kaplan–Meier plots of median (A) progression-free survival and (B) OS in the TACE plus sorafenib and TACE alone groups.

Abbreviations: HR, hazard ratio; TACE, transarterial chemoembolization; CI, confidence interval.